Ertapenem is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Ertapenem Sodium.
Product ID | 63323-823_8a08dc4b-9129-4b04-b586-19ca10abeafb |
NDC | 63323-823 |
Product Type | Human Prescription Drug |
Proprietary Name | Ertapenem |
Generic Name | Ertapenem Sodium |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2019-10-10 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA208790 |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | ERTAPENEM SODIUM |
Active Ingredient Strength | 1 g/1 |
Pharm Classes | Carbapenems [CS], Penem Antibacterial [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-10-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA208790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-10-10 |
Marketing Category | ANDA |
Application Number | ANDA208790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-10-10 |
Ingredient | Strength |
---|---|
ERTAPENEM SODIUM | 1 g/1 |
SPL SET ID: | 666c9f33-ea9e-4667-b8bd-f8b1b6b6be51 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-3510 | Ertapenem | Ertapenem |
42023-221 | ERTAPENEM | ertapenem sodium |
44567-820 | ertapenem | ertapenem |
44647-051 | Ertapenem | Ertapenem Sodium |
55150-282 | Ertapenem | Ertapenem |
60505-6196 | Ertapenem | Ertapenem Sodium |
63323-823 | Ertapenem | Ertapenem |
68001-408 | Ertapenem | Ertapenem |
0143-9398 | ertapenem sodium | ertapenem sodium |
16714-889 | ERTAPENEM SODIUM | Ertapenem |
43598-901 | ERTAPENEM SODIUM | Ertapenem |
0006-3843 | INVANZ | ertapenem sodium |